" class="no-js "lang="en-US"> Alain Maiore - Medtech Alert
Thursday, September 18, 2025
Alain Maiore

Alain Maiore

About Alain Maiore

Alain is the Co-founder and CEO of Mnemo Therapeutics, a transatlantic biotechnology company focused on creating powerful CAR T immunotherapies to treat solid tumors and blood cancers. He is an experienced leader, fueled by a passion to bring life-saving therapies to patients. As a multi-serial entrepreneur and venture capitalist with over 30 years of expertise that spans across Europe and the US, he brings a powerful combination of expertise in company creation, growth, turn around, and venture investment. At Mnemo he has helped to grow a team that shares his values and his vision, with an unrelenting drive to create cures and deliver breakthrough technologies for patients.

Related Story

Mnemo Therapeutics Announces €75 million Series A to Accelerate Next Generation Integrated CAR-T and Epigenetic Targeting Platform

June 18 2021

Mnemo Therapeutics, a biotechnology company developing powerful cell therapies using a novel target identification engine, […]